REQUEST A DEMO
Total
USD $0.00
Search more companies

Taisho Pharmaceutical (M) Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Taisho Pharmaceutical (M) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Taisho Pharmaceutical (M) Sdn. Bhd. is based in Malaysia, with the head office in Petaling Jaya. The company operates in the Pharmacies and Drug Stores sector. It was first established on September 22, 1990. The company’s latest financial report indicates a net sales revenue drop of 2.15% in 2022. Its total assets grew by 3.97% over the same period.

Headquarters
Unit B-3A-3A, Dataran 32, No. 2 Jalan 19/1
Petaling Jaya; Selangor; Postal Code: 46300

Contact Details: Purchase the Taisho Pharmaceutical (M) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Taisho Pharmaceutical (M) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Taisho Pharmaceutical (M) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Taisho Pharmaceutical (M) Sdn. Bhd. report to view the information.
Incorporation Date:
September 22, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Taisho Pharmaceutical (M) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.15%
Total operating revenue
-2.15%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
3.97%
Total equity
3.46%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.62%
Cash Ratio
0.39%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?